Pharmaceutical Fluid Handling Global Market Report 2024

The pharmaceutical fluid handling market size has grown steadily in recent years. It will grow from $11.24 billion in 2023 to $11.78 billion in 2024 at a compound annual growth rate (CAGR) of 4.8%. The growth observed in the historical period can be attributed to various factors, including adherence to regulatory standards and compliance, the integration of technology, an emphasis on quality control, innovation in drug delivery methods, and the adoption of laboratory automation practices.

The pharmaceutical fluid handling market size is expected to see strong growth in the next few years. It will grow to $14.44 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The anticipated growth in the forecast period can be attributed to factors such as the advancement of precision medicine and personalized therapies, an increase in biologics manufacturing, the growing trend of outsourcing in the pharmaceutical industry, the expansion of emerging markets, and the adoption of flexible manufacturing platforms. Significant trends expected in the forecast period encompass a heightened focus on training and skill development in the pharmaceutical industry, the development of closed systems for manufacturing, the emergence of decentralized manufacturing models, increased utilization of nanotechnology, and the integration of smart sensors and IoT devices in pharmaceutical fluid handling.

The anticipated rise in pharmaceutical drug production is poised to drive the expansion of the pharmaceutical fluid handling market in the foreseeable future. Drug production encompasses the manufacturing process of pharmaceutical substances, medications, or drugs. Facilitating drug production, pharmaceutical fluid handling plays a crucial role by ensuring the precise and efficient handling, transfer, and containment of liquids and fluids throughout the manufacturing process. As of June 2022, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported that the total pharmaceutical production in Europe reached $351 billion (€300,000 million) in 2021, marking an approximate 5% increase from $335.2 billion (€286,697 million) in 2020. Thus, the escalating demand for pharmaceutical drugs is identified as a key driver propelling the growth of the pharmaceutical fluid handling market.

Stringent regulatory requirements within the pharmaceutical industry are significantly contributing to the burgeoning growth of the pharmaceutical fluid handling market. These stringent regulatory requirements encompass the rigorous rules, standards, and guidelines established by government authorities and regulatory agencies to uphold the safety, efficacy, and quality of pharmaceutical products. The necessity for adherence to high-quality and compliant fluid handling systems arises from these strict regulatory requirements to ensure product quality, safety, and compliance with good manufacturing practices (GMP). For example, in May 2023, the EU Commission submitted proposals for new legislation on pharmaceuticals aimed at enhancing security of supply and addressing shortages through specific measures. Consequently, the stringent regulatory landscape is expected to propel the pharmaceutical fluid handling market.

The advent of automated fluid handling systems emerges as a notable trend gaining traction in the pharmaceutical fluid handling market. Companies operating in this market are introducing automated fluid handling systems equipped with a fluidic application programming interface (API) to maintain their competitive standing. A case in point is Festo, a Germany-based automation company, which launched a modular gantry robot platform for automated liquid handling in laboratories in February 2022. This platform, designed for a wide range of media, calibrations, and targeted operations in laboratories, features a fluidic application programming interface (API) with Python, Java, and .NET/C# drivers, facilitating easy development and optimization of strategies for the machine and supporting end users in fluid handling processes. This innovation eliminates the need for original equipment manufacturers (OEMs) to acquire generic machines and facilitates the smooth adoption of new technology.

Major players in the pharmaceutical fluid handling market are concentrating on the development of robotics tailored for pharmaceutical fluid handling applications. The integration of automation and robotic technologies into fluid handling systems aims to enhance efficiency, accuracy, and reproducibility in pharmaceutical manufacturing processes. A notable example is Cellular Origins, a UK-based manufacturer of automated cell and gene therapy, which introduced Constellation A, a closed, fully automated, and configurable robotic platform for cell therapy in May 2023. This platform boasts end-to-end digital interconnection, complete with fully remote digital control and analytics, as well as quality control systems.

In February 2021, SPT Labtech, a UK-based manufacturer of liquid handling instruments, acquired Apricot Designs Inc. for an undisclosed amount. This strategic acquisition enables SPT Labtech to diversify and enrich its liquid handling technologies and instruments portfolio by incorporating Apricot Designs' pharmaceutical liquid handling solutions. Apricot Designs Inc. is a US-based company specializing in the manufacturing of laboratory equipment and liquid handling instruments.

Major companies operating in the pharmaceutical fluid handling market report are Pfizer Inc., Johnson & Johnson Pvt. Ltd., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., GlaxoSmithKline PLC, Danaher Corporation, Gilead Sciences Inc., Amgen Inc., Parker Hannifin Corporation, Corning Incorporated, Agilent Technologies Inc., Alfa Laval AB, PerkinElmer Inc., Spirax Sarco Engineering PLC, Eppendorf AG, Tecan Trading AG, CIRCOR International Inc., Raumedic AG, Borosil Glass Works Ltd., BioTek Instruments Inc., Labcyte Inc., Gilson Company Inc., Aurora Biomed Inc., Tef Cap Industries Inc., Labnet International Inc., Australian Fluid Handling Pty Ltd., Fraser Ross Ltd.

North America was the largest region in the pharmaceutical fluid handling market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical fluid handling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical fluid handling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main offerings in pharmaceutical fluid handling include equipment and solutions, as well as services. Equipment and solutions comprise tools, machinery, systems, and comprehensive offerings designed to address specific needs or challenges in various industries or applications. Various types of tubing, such as thermoplastic elastomers, polyvinyl chloride, and silicone, are employed for different purposes, including applications such as cough syrup, intravenous products, and complex active pharmaceutical ingredients. These materials find usage in diverse applications such as fluid handling and management, fluid preparation, integration and automation, buffer management, and others. The end-users of pharmaceutical fluid handling include biotechnology companies, pharmaceutical and medical companies, among others.

The pharmaceutical fluid handling market research report is one of a series of new reports that provides pharmaceutical fluid handling market statistics, including pharmaceutical fluid handling industry global market size, regional shares, competitors with a pharmaceutical fluid handling market share, detailed pharmaceutical fluid handling market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical fluid handling industry. This pharmaceutical fluid handling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical fluid handling market consists of revenues earned by entities by providing services such as fluid transfer, storage, filtration, mixing, blending, and dispensing of various liquids and solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical fluid handling market also includes sales of pumps, micropipettes, valves, pipets, filters, mixers, stackers, washers, handlers, containers, and robotic systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.